FABP5 mainly regulates fat metabolism and transfer, studies have found that FABP5 is an important mediator in increasing resistance to chemotherapy drugs, and high levels of FABP5 correlate with MM aggressiveness and poor prognosis30. Here, FABP5 is linked to Miyoshi myopathy.